Gender difference in the mean age at the induction of hemodialysis in patients with autosomal dominant polycystic kidney disease

被引:33
|
作者
Ishikawa, I [1 ]
Maeda, K [1 ]
Nakai, S [1 ]
Kawaguchi, Y [1 ]
机构
[1] Kanazawa Med Univ, Dept Internal Med, Div Nephrol, Kanazawa, Ishikawa 9200293, Japan
关键词
autosomal dominant polycystic kidney disease (ADPKD); diabetic nephropathy; gender; glomerulonephritis; hemodialysis (HD);
D O I
10.1016/S0272-6386(00)70042-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Male patients with autosomal dominant polycystic kidney disease (ADPKD) begin hemodialysis earlier than female patients, The rate of progression of many other renal diseases is also faster in men than women. In this study, gender difference in ADPKD was compared with that in other diseases, such as chronic glomerulonephritis, diabetic nephropathy, and nephrosclerosis, using the data obtained from an annual statistical survey of the Japanese Society for Dialysis Therapy, The male-female ratio in ADPKD (n = 8,176) was 1.17:1 and closer to 1.0:1 than the other diseases. Men with ADPKD started hemodialysis therapy 1.3 years earlier than women (male age, 55.9 +/- 12.4 years versus female age, 57.2 +/- 11.5 years), and the age difference was less than that in other diseases. These results suggest that the prognosis in women with ADPKD is relatively worse than that in men with ADPKD or that women are not well protected against the progression of this disease compared with other renal diseases. In conclusion, men with ADPKD are introduced to hemodialysis therapy earlier than women; however, the age difference was small compared with other common renal diseases. (C) 2000 by the National Kidney Foundation, Inc.
引用
收藏
页码:1072 / 1075
页数:4
相关论文
共 50 条
  • [1] Complications of autosomal dominant polycystic kidney disease in hemodialysis patients
    Norby, SM
    Torres, VE
    SEMINARS IN DIALYSIS, 2000, 13 (01) : 30 - 35
  • [2] Clinical problems in hemodialysis patients with autosomal dominant polycystic kidney disease
    Kocyigit, Ismail
    Eroglu, Eray
    Gungor, Ozkan
    SEMINARS IN DIALYSIS, 2018, 31 (03) : 268 - 277
  • [3] Abdominal aortic aneurysms in hemodialysis patients with autosomal dominant polycystic kidney disease
    Kato, A
    Takita, T
    Furuhashi, M
    Maruyama, Y
    Hishida, A
    NEPHRON, 2001, 88 (02): : 185 - 186
  • [4] Cinacalcet may suppress kidney enlargement in hemodialysis patients with autosomal dominant polycystic kidney disease
    Shinya Nakatani
    Kozo Nishide
    Senji Okuno
    Eiji Ishimura
    Daijiro Kabata
    Fumiyuki Morioka
    Yuri Machiba
    Hideki Uedono
    Akihiro Tsuda
    Shigeichi Shoji
    Masaaki Inaba
    Katsuhito Mori
    Tomoyuki Yamakawa
    Masanori Emoto
    Scientific Reports, 11
  • [5] Cinacalcet may suppress kidney enlargement in hemodialysis patients with autosomal dominant polycystic kidney disease
    Nakatani, Shinya
    Nishide, Kozo
    Okuno, Senji
    Ishimura, Eiji
    Kabata, Daijiro
    Morioka, Fumiyuki
    Machiba, Yuri
    Uedono, Hideki
    Tsuda, Akihiro
    Shoji, Shigeichi
    Inaba, Masaaki
    Mori, Katsuhito
    Yamakawa, Tomoyuki
    Emoto, Masanori
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [6] The survival rate of hemodialysis patients with autosomal dominant polycystic kidney disease: A multicenter study
    Sotirakopoulos, N
    Tsitsios, T
    Stambolidou, M
    Papanastasiou, S
    Konstantinidis, TK
    Mavromatidis, K
    DIALYSIS & TRANSPLANTATION, 2001, 30 (11) : 740 - +
  • [7] Variation in age at ESRD in autosomal dominant polycystic kidney disease
    Reed, Berenice Y.
    McFann, Kim
    Bekheirnia, M. Reza
    Nobkhthaghighi, Nilootar
    Masoumi, Amirali
    Johnson, Ann M.
    Shamshiraz, Alireza Abdollah
    Kelleher, Catherine L.
    Schrier, Robert W.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (02) : 173 - 183
  • [8] CAPD in patients with autosomal dominant polycystic kidney disease
    Hadimeri, H
    Johansson, AC
    Haraldsson, B
    Nyberg, G
    PERITONEAL DIALYSIS INTERNATIONAL, 1998, 18 (04): : 429 - 432
  • [9] Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
    Torres, Vicente E.
    Chapman, Arlene B.
    Devuyst, Olivier
    Gansevoort, Ron T.
    Grantham, Jared J.
    Higashihara, Eiji
    Perrone, Ronald D.
    Krasa, Holly B.
    Ouyang, John
    Czerwiec, Frank S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25): : 2407 - 2418
  • [10] Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
    Walz, Gerd
    Budde, Klemens
    Mannaa, Marwan
    Nuernberger, Jens
    Wanner, Christoph
    Sommerer, Claudia
    Kunzendorf, Ulrich
    Banas, Bernhard
    Hoerl, Walter H.
    Obermueller, Nicholas
    Arns, Wolfgang
    Pavenstaedt, Hermann
    Gaedeke, Jens
    Buechert, Martin
    May, Christoph
    Gschaidmeier, Harald
    Kramer, Stefan
    Eckardt, Kai-Uwe
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (09): : 830 - 840